Mutational inactivation of transforming growth factor β receptor type II in microsatellite stable colon cancers

Cancer Research

Volumn 59, Issue 2, 1999, Pages 320-324

  Grady, William M ^a,b   Myeroff, Lois L ^b   Swinler, Sandra E ^b   Rajput, Ashwani ^c   Thiagalingam, Sam ^e   Lutterbaugh, James D ^b,f   Neumann, Aaron ^c   Brattain, Michael G ^b   Chang, Jay ^d   Kim, Seong Jin ^d   Kinzler, Ken W ^e   Vogelstein, Bert ^e,f   Willson, James K V ^a,b   Markowitz, Sanford ^a,b,f,g  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g Ireland Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; COLON CANCER; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADULT; COLONIC NEOPLASMS; FEMALE; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0033555627     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Markowitz, S., and Roberts, A. Tumor supressor activity of the TGF-β pathway in human cancers. Cytokine Growth Factor Rev., 7: 93-102, 1996.
2. Moses, H., Yang, E., and Pietonpol, J. TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell, 63: 245-247, 1990.
3. Markowitz, S., Myeroff, L., Cooper, M., Traicoff, J., Kochera, M., Lutterbaugh, J., Swiriduk, M., and Willson, J. A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes but progresses to tumorigenicity and transforming growth factor-β independence without inactivating the p53 tumor suppressor gene. J. Clin. Investig., 93: 1005-1013, 1994.
4. Wang, C. Y., Eshleman, J., Willson, J., and Markowitz, S. TGF-β and substrate release are both inducers of apoptosis in a human colon adenoma cell line. Cancer Res., 55: 5101-5105, 1995.
5. Massagué, J., Attisano, L., and Wrana, J. The TGF-β family and its composite receptors. Trends Cell Biol., 6: 172-178, 1985.
6. Eshleman, J., and Markowitz, S. Mismatch repair defects in human carcinogenesis. Hum. Mol. Genet., 5: 1489-1494, 1996.
7. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R., Zborowska, E., Kinzler, K., Vogelstein, B., Brattain, M., and Willson, J. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science (Washington DC), 268: 1336-1338, 1995.
8. Myeroff, L., Parsons, R., Kim, S-J., Hedrick L. Cho K., Orth K. Mathis, M., Kinzler, K., Lutterbaugh, J., Park, K., Bang, Y-J., Lee, H., Park, J-G., Lynch, H., Roberts, A., Vogelstein, B., and Markowitz, S. A transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res., 55: 5545-5547, 1995.
9. Parsons, R., Myeroff, L., Liu, B., Willson, J., Markowitz, S., Kinzler, K., and Vogelstein, B. Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res., 55: 5548-5550, 1995.
10. Wang, J., Sun, L., Myeroff, L., Wang, X., Gentry, L., Yang, J., Liang, J., Zborowska, E., Markowitz, S., Willson, J., and Brattain, M. Demonstration that mutation of the type II transforming growth factor β receptor inactivates its tumor supressor activity in replication error-positive colon carcinoma cells. J. Biol. Chem., 270: 22044-22049, 1995.
11. Takenoshita, S., Tani, M., Nagashima, M., Hagiwara, K., Bennet, W., Yokota, J., and Harris, C. Mutation analysis of coding sequences of the entire transforming growth factor β type II receptor gene in sporadic human colon cancer using genomic DNA and intron primers. Oncogene, 14: 1255-1258, 1997.
12. Willson, J., Bittner, G., Oberley, T., Meisner, G., and Weese, J. Cell culture of human colon adenomas and carcinomas. Cancer Res., 47: 2704-2713, 1987.
13. Thiagalingam, S., Lengauer, C. Leach, F., Schutte, M., Hahn, S., Overhauser, J., Willson, J., Markowitz, S., Hamilton, S., Kern, S., Kinzler, K., and Vogelstein, B. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat. Genet., 13: 343-346, 1996.
14. Riggins, G., Thiagalingam, S., Rozenblum, E., Weinstein, C., Kern, S., Hamilton, S., Willson, J., Markowitz, S., Kinzler, K., and Vogelstein, B. Mad-related genes in the human. Nat. Genet., 13: 347-349, 1996.
15. Grady, W., Rajput, A., Myeroff, L., Liu, D., Kwon, K-H., Willis, J., and Markowitz, S. Mutation of the type II transforming growth factor-β receptor is coincident with the transformation of human colon adenomas to malignant carcinomas. Cancer Res., 58: 3101-3104, 1998.
16. Wrana, J., Attisano, L., Carcamo, J., Zentella, A., Doody, J., Laiho, M., Wang X-F., and Massagué, J. TGFβ signals through a heteromeric protein kinase receptor complex. Cell, 71: 1003-1014, 1992.
17. Chang, J., Park, K., Bang, Y-J., Kim, W., Kim, D., and Kim, S-J. Expression of transforming growth factor β type II receptor reduces tumorigenicity in human gastric cancer cells. Cancer Res., 57: 2856-2859, 1997.
18. Eshleman, J., and Markowitz, S. Microsatellite instability in inherited and sporadic neoplasms. Curr. Opin. Oncol., 7: 83-89, 1995.
19. Lin, H. Y., Wang, X-F., Ng-Eaton, E., Weinberg, R. A., and Lodish, H. F. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell, 68: 775-785, 1992.
20. Derynck, R., and Feng, X-H. TGF-β receptor signaling. Biochim. Biophys. Acta, 1333: F105-F150, 1997.
21. Garrigue-Antar, L., Munoz-Antonia, T., Antonia, S., Gesmonde, J., Vellucci, V., and Reiss, M. Missense mutations of the transforming growth factor β type II receptor in human head and neck squamous carcinoma cells. Cancer Res., 55: 3982-3987, 1995.
22. Knaus, P., Lindemann, D., DeCoteau, J., Perman, R., Yankelev, H., Hille, M., Kandin, M., and Lodish, H. A dominant inhibitory mutant of the type II transforming growth factor β receptor in the malignant progression of a cutaneous T-cel lymphoma. Mol. Cell. Biol., 16: 3480-3489, 1996.
23. Macias-Silva, M., Abdollah, S., Hoodless, P., Pirone, R., Attisano, L., and Wrana, J. MADR2 is a substrate of the TGFβ receptor, and its phosphorylation is requited for nuclear accumulation and signaling. Cell, 87: 1215-1224, 1996.
24. Massagué, J. TGF-β signaling: receptors, transducers, and mad proteins. Cell, 85: 947-950, 1996.
25. Riggins, G., Kinzler, K., Vogelstein, B., and Thiagalingam, S. Frequency of smad gene mutations in human cancers. Cancer Res., 57: 2578-2580, 1997.
26. Eppert, K., Scherer, S., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsui, L-C., Bapat, B., Gallinger, S., Andrulis, I., Thomsen, G., Wrana, J., and Attisano, L. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal cancer. Cell, 86: 543-552, 1996.
27. Schutte, M., Hruban, R., Hedrick, L., Cho, K., Nadasdy, G., Weinstein, C., Bova, G., Isaacs, W., Cairns, P., Nawroz., H., Sidransky, D., Casero, R., Meltzer, P., Hahn, S., and Kern, S. DPC4 gene in various tumor types. Cancer Res., 56: 2527-2530, 1996.
28. Takaku, K., Oshima, M., Miyoshi, H., Matsui, M., Seldin, M., and Taketo, M. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell, 92: 645-656, 1998.
29. Zhu, Y., Richardson, J., Parada, L., and Graff, J. Smad3 mutant mice develop metastatic colorectal cancer. Cell, 94: 703-714, 1998.